Skip to content 
Pharmaceutical market
The product is available under the brand names of Nicozid and Nyazid, manufactured by well-known pharmaceutical industries. It is also available in combination with Rifampicin and Ethambutol under the brand name Rimifon for patients who have a history of recurring tuberculosis. This gives a more rigorous treatment to the bacteria. The tables are available in the strengths of 100 mg and 300 mg, but intramuscular injections are also stocked in the hospital markets for use when required.
References
Murray, J. F. (2015, October 14). Treatment of Tuberculosis. A Historical Perspective. Annals of the American Thoracic Society.
NCBI – Isoniazid: A Review of Characteristics, Properties, and Analytical Methods. (2017, July). NCBI.
Isoniazid. (2008, March 1). ScienceDirect.
Isoniazid: Uses, Interactions, Mechanism of Action | DrugBank Online. (2005). DrugBank.
(Isoniazid) dosing, indications, interactions, adverse effects, and more. (2020, May 28). Medscape.
Isoniazid | Michigan Medicine. (2017, October 16). Michigan Medicine.
Brown, H. (1955). Allergy to Isoniazid. American Review of Tuberculosis and Pulmonary Diseases.
Isoniazid: Uses, Interactions, Mechanism of Action | DrugBank Online. (2005b). DrugBank.
